Advertisement

Topics

J&J taps German Merck to market Invokana in China

20:20 EDT 12 Jul 2018 | BioPharmaDive

Diabetes became a major health issue in China over last few decades. Though that offers a big market opportunity, commercializing products remains tricky.

Original Article: J&J taps German Merck to market Invokana in China

NEXT ARTICLE

More From BioPortfolio on "J&J taps German Merck to market Invokana in China"

Advertisement
Quick Search
Advertisement
Advertisement